1. A SARS-CoV-2 related signature that explores the tumor microenvironment and predicts immunotherapy response in esophageal squamous cell cancer
   Qianhe Ren et al, 2023, Aging CrossRef
2. Is it possible to identify COVID-19 infection-related biomarkers during pregnancy?: A prospective study in Turkish population
   İlke Özer Aslan et al, 2024, Medicine CrossRef
3. CTSL, a prognostic marker of breast cancer, that promotes proliferation, migration, and invasion in cells in triple-negative breast cancer
   Lianmei Zhang et al, 2023, Frontiers in Oncology CrossRef
4. New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19
   Ting Li et al, 2023, Frontiers in Immunology CrossRef
5. A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers
   Wenqian Zhang et al, 2024, Frontiers in Immunology CrossRef
6. Diabetic individuals with COVID-19 exhibit reduced efficacy of gliptins in inhibiting dipeptidyl peptidase 4 (DPP4). A suggested explanation for increased COVID-19 susceptibility in patients with type 2 diabetes mellitus (T2DM)
   José María Mora-Rodríguez et al, 2024, Life Sciences CrossRef
7. Comprehensive analysis, immune, and cordycepin regulation for SOX9 expression in pan-cancers and the matched healthy tissues
   Shuguang Liu et al, 2023, Frontiers in Immunology CrossRef
8. TMX family genes and their association with prognosis, immune infiltration, and chemotherapy in human pan-cancer
   Na Luo et al, 2023, Aging CrossRef
9. Comprehensive analysis, diagnosis, prognosis, and cordycepin (CD) regulations for GSDME expressions in pan-cancers
   Jiewen Fu et al, 2024, Cancer Cell International CrossRef
10. Changes in Adenosine Deaminase Activity and Endothelial Dysfunction after Mild Coronavirus Disease-2019
    Agata Jedrzejewska et al, 2023, International Journal of Molecular Sciences CrossRef